Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 13 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Apparatus and method for transmitting and receiving data streams in wireless system
EpCAM as a reprogramming factor for non-pluripotent cells
Control method of LPI lamp for LPI vehicle and logic therefor
Diazeniumdiolated phosphorylcholine polymers for nitric oxide release
Systems and/or methods for using air/wind power to charge/re-charge vehicle batteries
Developing device
Controlling transmission resources in mobile radio systems with dualtransfer mode
  Randomly Featured Patents
Photographic enlarging apparatus
Power down protection circuit for an electronic device
Segmented image holographic disks
Method for making an electrical contact to a silicon substrate through a relatively thin layer of silicon dioxide on the surface of the substrate
Magnetically restored golf practice device
Power management architecture including a power management messaging bus for conveying an encoded activity signal for optimal flexibility
Semicontinuous process for deodorizing oils
Endoscope light source unit
Timing regenerating device
Methods for efficacious removal of attached, sucking antropods from human dermis